{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:48:48Z","timestamp":1775627328360,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early and accurate differentiation of prostate cancer (PC) from benign prostatic hyperplasia (BPH) remains challenging; metabolomics enables biomarker discovery by capturing disease-specific metabolic changes. The study includes 64 expressed prostatic secretion from 31 PC cases and 33 BPH cases. Nuclear magnetic resonance spectroscopy was used for metabolomics. Multivariate analyses, including principal component analysis, orthogonal partial least squares discriminant analysis, and artificial neural network modelling, were performed to identify discriminative metabolites. Diagnostic performance was assessed using receiver operating characteristic curve analysis. Clinical correlations with prostate-specific antigen (PSA) levels, multiparametric MRI (mpMRI), and Gleason score (GS) were executed. Citrate, glutamate, myo-inositol, and cis-aconitate were identified as key metabolites distinguishing PC from BPH, showing significant correlations with PSA, mpMRI-derived Prostate Imaging Reporting and Data System scores and apparent diffusion coefficient values as well as histopathology-based GS. The identified metabolic signature demonstrates strong potential as a noninvasive tool to support early PC detection and clinical decision-making, showing correlation with PSA, mpMRI indices and GS to enhance diagnostic accuracy before structural changes become evident.<\/jats:p>","DOI":"10.1093\/molecular-omics\/aaiag013","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:06:43Z","timestamp":1775066803000},"source":"Crossref","is-referenced-by-count":0,"title":["Prostate cancer: metabolic remodelling in expressed prostatic secretions reveals cellular structural changes measured by mpMRI"],"prefix":"10.1093","volume":"22","author":[{"given":"Anuj","family":"Kumar","sequence":"first","affiliation":[{"name":"Centre of Biomedical Research, Sanjay Gandhi Postgraduate Institute of Medical Sciences Campus , Lucknow 226014 ,","place":["India"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , Ghaziabad 201002 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Ranjan","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow 226014 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow 226014 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash D","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow 226014 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira","family":"Lal","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow 226014 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavindra","family":"Nath","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday P","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences , Lucknow 226014 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-9067","authenticated-orcid":false,"given":"Ashish","family":"Gupta","sequence":"additional","affiliation":[{"name":"Centre of Biomedical Research, Sanjay Gandhi Postgraduate Institute of Medical Sciences Campus , Lucknow 226014 ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026040801024864700_ref1","first-page":"7","article-title":"Cancer statistics 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2026040801024864700_ref2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.urolonc.2012.05.012","article-title":"Defining prostate cancer risk before prostate biopsy","volume":"31","author":"Pal","year":"2013","journal-title":"Urol Oncol"},{"key":"2026040801024864700_ref3","first-page":"357","article-title":"PSA testing: when it\u2019s useful, when it\u2019s not","volume":"60","author":"Slatkoff","year":"2011","journal-title":"The J Fam Prac"},{"key":"2026040801024864700_ref4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1586\/14737159.2016.1164037","article-title":"NMR-based metabolomics of prostate cancer: a protagonist in clinical diagnosis","volume":"16","author":"Kumar","year":"2016","journal-title":"Exp Rev Mole Diag"},{"key":"2026040801024864700_ref5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/14789450.2021.2011225","article-title":"Non-invasive urine metabolomics of prostate cancer and its therapeutic approaches a current scenario and future perspective","volume":"18","author":"Kumar","year":"2021","journal-title":"Exp Rev Proteo"},{"key":"2026040801024864700_ref6","first-page":"1","article-title":"Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review","volume":"24","author":"Bansal","year":"2022","journal-title":"Exp Rev Mole Med"},{"key":"2026040801024864700_ref7","first-page":"1","article-title":"Evaluation of prostate cancer tissue metabolomics: would clinics utilise it for diagnosis?","volume":"25","author":"Bansal","year":"2023","journal-title":"Exp Rev Mole Med"},{"key":"2026040801024864700_ref8","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.juro.2006.07.054","article-title":"Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection","volume":"176","author":"Kline","year":"2006","journal-title":"J Urol"},{"key":"2026040801024864700_ref9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/pros.20727","article-title":"The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions","volume":"68","author":"Serkova","year":"2008","journal-title":"Prostate"},{"key":"2026040801024864700_ref10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jprot.2009.01.007","article-title":"Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease","volume":"72","author":"Drake","year":"2009","journal-title":"J Proteome"},{"key":"2026040801024864700_ref11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1021\/pr2011236","article-title":"Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine","volume":"11","author":"Principe","year":"2012","journal-title":"J Proteome Res"},{"key":"2026040801024864700_ref12","doi-asserted-by":"publisher","first-page":"107153","DOI":"10.1016\/j.bpc.2023.107153","article-title":"Richer than previously probed: an application of 1H NMR reveals one hundred metabolites using only fifty microliter serum","volume":"305","author":"Bansal","year":"2024","journal-title":"Biophys Chem"},{"key":"2026040801024864700_ref13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/rep.0.1220431","article-title":"A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites","volume":"122","author":"Sharma","year":"2001","journal-title":"Reproduction"},{"key":"2026040801024864700_ref14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"key":"2026040801024864700_ref15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1148\/radiol.2281011808","article-title":"Pathologic characterization of human prostate tissue with proton MR spectroscopy","volume":"228","author":"Swindle","year":"2003","journal-title":"Radiology"},{"key":"2026040801024864700_ref16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.urolonc.2012.09.008","article-title":"Progress in prostate cancer imaging","volume":"30","author":"Gulley","year":"2012","journal-title":"Urol Oncol"},{"key":"2026040801024864700_ref17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1593\/neo.101102","article-title":"Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research","volume":"13","author":"Kurhanewicz","year":"2011","journal-title":"Neoplasia"},{"key":"2026040801024864700_ref18","doi-asserted-by":"publisher","first-page":"198ra108","DOI":"10.1126\/scitranslmed.3006070","article-title":"Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate","volume":"5","author":"Nelson","year":"2013","journal-title":"Sci Transl Med"},{"key":"2026040801024864700_ref19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10334-008-0136-0","article-title":"Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology","volume":"21","author":"Swindle","year":"2008","journal-title":"MAGMA"},{"key":"2026040801024864700_ref20","doi-asserted-by":"publisher","first-page":"114333","DOI":"10.1016\/j.jpba.2021.114333","article-title":"Metabolomics of prostate cancer: knock-in versus knock-out prostate","volume":"205","author":"Kumar","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"2026040801024864700_ref21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/01.ju.0000148949.72314.d7","article-title":"A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma","volume":"173","author":"Averna","year":"2005","journal-title":"J Urol"},{"key":"2026040801024864700_ref22","doi-asserted-by":"publisher","first-page":"e2024357119","DOI":"10.1073\/pnas.2024357119","article-title":"Carbon sources and pathways for citrate secreted by human prostate cancer cells determined by NMR tracing and metabolic modelling","volume":"119","author":"Heijster","year":"2022","journal-title":"PNAS"},{"key":"2026040801024864700_ref23","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","article-title":"Metabolic adaptations in prostate cancer","volume":"131","author":"Pujana-Vaquerizo","year":"2024","journal-title":"British J Cancer"},{"key":"2026040801024864700_ref24","doi-asserted-by":"publisher","first-page":"12168","DOI":"10.3390\/ijms232012168","article-title":"Enhanced succinate oxidation with mitochondrial complex II reactive oxygen species generation in human prostate cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026040801024864700_ref25","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.18632\/oncotarget.6370","article-title":"Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and Gleason score-specific metabolomic alterations in prostate cancer","volume":"7","author":"Meller","year":"2016","journal-title":"Oncotarget"},{"key":"2026040801024864700_ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5616807","article-title":"Broad spectrum anticancer activity of myo-inositol and inositol hexakisphosphate","volume":"2016","author":"Bizzarri","year":"2016","journal-title":"Int J Endocrin"},{"key":"2026040801024864700_ref27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2174\/092986712799034888","article-title":"Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer","volume":"19","author":"Barinka","year":"2012","journal-title":"Cur Med Chem"},{"key":"2026040801024864700_ref28","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1158\/1078-0432.CCR-12-1308","article-title":"Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells","volume":"18","author":"Koochekpour","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2026040801024864700_ref29","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/s41598-020-60616-z","article-title":"Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"2026040801024864700_ref30","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1021\/acs.jproteome.0c00091","article-title":"1H NMR-based urine metabolomics reveals sign of enhanced carbon and nitrogen recycling in prostate cancer","volume":"19","author":"Bruzzone","year":"2020","journal-title":"J Proteome Res"},{"key":"2026040801024864700_ref31","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.3390\/molecules25204597","article-title":"NMR as a \u201cgold standard\u201d method in drug design and discovery","volume":"25","author":"Emwas","year":"2020","journal-title":"Molecules"},{"key":"2026040801024864700_ref32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas","year":"2019","journal-title":"NMR spectroscopy for metabolomics research Metabolites"},{"key":"2026040801024864700_ref33","doi-asserted-by":"crossref","first-page":"8694","DOI":"10.1039\/D1RA01103K","article-title":"NMR-based metabolomics with enhanced sensitivity","volume":"11","author":"Chandra","year":"2021","journal-title":"RSC Adv"},{"key":"2026040801024864700_ref34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1039\/D1MO00118C","article-title":"The robust NMR toolbox for metabolomics","volume":"17","author":"Chandra","year":"2021","journal-title":"Mol Omics"},{"key":"2026040801024864700_ref35","doi-asserted-by":"publisher","first-page":"23651","DOI":"10.1021\/acsomega.3c01688","article-title":"Compound-specific 1D 1H NMR pulse sequence selection for metabolomics analyses","volume":"8","author":"Singh","year":"2023","journal-title":"ACS Omega"},{"key":"2026040801024864700_ref36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11306-023-02069-9","article-title":"Improving quality of analysis by suppression of unwanted signals through band-selective excitation in NMR spectroscopy for metabolomics studies","volume":"20","author":"Singh","year":"2023","journal-title":"Metabolomics"},{"key":"2026040801024864700_ref37","doi-asserted-by":"publisher","first-page":"26873","DOI":"10.1039\/D4RA03019B","article-title":"Enhancement of weak signals by applying a suppression method to high-intense methyl and methylene signals of lipids in NMR spectroscopy","volume":"14","author":"Singh","year":"2024","journal-title":"RSC Adv"}],"container-title":["Molecular Omics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/advance-article-pdf\/doi\/10.1093\/molecular-omics\/aaiag013\/67715567\/aaiag013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/2\/aaiag013\/67715567\/aaiag013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/22\/2\/aaiag013\/67715567\/aaiag013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:02:53Z","timestamp":1775624573000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/doi\/10.1093\/molecular-omics\/aaiag013\/8571427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1093\/molecular-omics\/aaiag013","relation":{},"ISSN":["2515-4184"],"issn-type":[{"value":"2515-4184","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]},"article-number":"aaiag013"}}